Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Volunteers must be non-smokers for at least 6 months before first study drug administration~* Volunteers must consume no more than 4 to 5 cups of coffee or tea or 8 cans of cola each day~Exclusion Criteria:~* History of or currently active illness considered to be clinically significant by the Investigator or any other illness that the Investigator considers should exclude the patient from the study or that could interfere with the interpretation of the study results~* Female volunteer is breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Sequence 1: Treatment A-B-C (Type: EXPERIMENTAL): The study consists of 3 single-dose treatment periods. Each treatment period will be 5 days in duration. Successive treatment periods will be separated by a washout period (with no medication) of 10 days.
- Sequence 2: Treatment B-C-A (Type: EXPERIMENTAL): The study consists of 3 single-dose treatment periods. Each treatment period will be 5 days in duration. Successive treatment periods will be separated by a washout period (with no medication) of 10 days.
- Sequence 3: Treatment C-A-B (Type: EXPERIMENTAL): The study consists of 3 single-dose treatment periods. Each treatment period will be 5 days in duration. Successive treatment periods will be separated by a washout period (with no medication) of 10 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).